Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00862927 · ClinicalTrials.gov registry record
Cue Reactivity in Virtual Reality: The Role of Context
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 21
- Enrollment target
NCT00862927: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT00862927 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00862927 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The objectives of this proposal are to examine the role of context in a virtual reality (VR) environment and to explore the extent to which cues (i.e., contextual cues or explicit smoking cues) influence craving and physiological arousal within VR. The current study seeks to determine whether smokers, placed in the context of a VR convenience store devoid of explicit smoking cues, will experience less craving and physiological arousal, compared to exposure to the same VR environment containing explicit smoking cues. This important line of inquiry will help clarify the influence of environmental contexts that may contribute to the overall reactivity effects (e.g., craving, arousal) smokers experience when confronted with cues associated with smoking.
Primary Outcome
Analyses on craving and arousal measures between-subjects to discern any differences in craving and arousal among the two sets of scenarios. After providing breath and saliva samples, seated participants complete questionnaires and smoke one cigarette to control for variability in time since last cigarette. First 5 questionnaires take approximately 35 minutes to complete, and another, completed after the VR session, approximately 10 minutes.
Interventions
- BEHAVIORAL Questionnaire
- OTHER Saliva Sample
- OTHER Breath Sample
- BEHAVIORAL View Virtual Reality Scenes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2009-03 |
| Est. Completion | 2011-07 |
Why NCT00862927 stopped before completion
NCT00862927 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Questionnaire is the first listed.
NCT00862927 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00862927 about?
NCT00862927 is a clinical study titled "Cue Reactivity in Virtual Reality: The Role of Context". The objectives of this proposal are to examine the role of context in a virtual reality (VR) environment and to explore the extent to which cues (i.e., contextual cues or explicit smoking cues) influence craving and physiological arousal within VR. The current study seeks to determine whether smoke...
What is the current status of trial NCT00862927?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2009-03. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00862927?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Saliva Sample (OTHER), Breath Sample (OTHER), View Virtual Reality Scenes (BEHAVIORAL).
Who is sponsoring clinical trial NCT00862927?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia